Optimal Duration Of Trastuzumab Therapy For Women With HER2+ Early Breast Cancer: New [Archive]

View Full Version : Optimal Duration Of Trastuzumab Therapy For Women With HER2+ Early Breast Cancer: New

News

10-03-2012, 02:13 AM

New studies that advance understanding of the optimal duration of therapy with the targeted cancer drug trastuzumab were released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna...

More... (http://www.medicalnewstoday.com/releases/250967.php)